fbpx

Male, 68 y/o

Patient internal ID: 9536279

ICD-10 code

C61 Malignant Neoplasm of Prostate

Diagnosis (incl metastases/stage) and year

2011
Carcinoma of the Prostate pT3N0M1 Gleason 7(4+3). In June of 2017 disease progression – Metastases to the Left Supraclavicular Lymph Nodes, Retroperitoneal Space.

Previous treatment

Surgery (Prostatectomy), Hormone Therapy (LHRH antagonists), Hormone Therapy (Abiraterone + Prednisolone), Chemotherapy (Docetaxel).

Prognosis and survival expectation

The prognosis remains poor, patients with Advanced Prostate cancer have a 5-year survival rate of close to 30%. The median survival is ~42 months from diagnosis.

Treatment provided

Autologous DCV (6 doses) over a period of 3 months. Additionally, the patient received Mistletoe Therapy.

Patient survival/condition and year

The patient has survived for 5,5 years since the disease progression. The patient had high Hepatic Toxicity from Chemotherapy Treatment. The patient received the DCV 6 months before death, therefore no conclusions can be made regarding the effectiveness.

Date of Review

01/01/2024